UNLOCKING THE POTENTIAL OF THE IMMUNE SYSTEM WITH A NEW
CLASS OF THERAPEUTICS

Unlocking the potential
of the immune system
with a new class of
therapeutics

Proprietary glycan polymer with platform potential
stimulates antigen capture, uptake, and
immunological responses
Intended to stimulate an immune response, thereby
enabling the rejection of cancer and other
diseases

Practical Applications to Elevate Modern Medicine

Transforming
Interventional
Oncology

Injecting IP-001 following routine tumor ablations may transform this conventional surgical intervention into a systemically active immunotherapy.

Read More

Elevating
Immunotherapy

IP-001 upregulates T-cell activation, downregulates T-cell exhaustion, and drives stronger Th-1 and cytotoxic T-cell response, which could enhance other immunotherapies, such as checkpoint inhibitors.

Read More

Boosting
Vaccines

IP-001 is a powerful immunoadjuvant that enhances antigen-specific immunity against infectious diseases, including SARS-CoV-2, potentially increasing the efficacy of vaccines.

Read More

Immunophotonics is dedicated to developing its proprietary technology for the benefit of global human health. We believe our multimodal of action approach can elevate modern medicine, allowing everyday-routine treatments to provide enhanced outcomes.

The Latest News

September 1, 2021

Immunophotonics Publishes Follow-up Feature in Nature Biopharma Dealmakers

Immunophotonics is excited to be featured in the September 2021 oncology issue of Nature Biopharma Dealmakers. Read what Dr. Markus...
Read More
March 1, 2021

Immunophotonics Featured in Nature Biopharma Dealmakers

Immunophotonics has been featured in the March oncology issue of Nature Biopharma Dealmakers (www.nature.com/articles/d43747-021-00020-2 ). Nature selects only a handful...
Read More
February 25, 2021

Study Shows IP-001 to Amplify Tumoricidal and Immune Effect of Cancer Ablation Therapies

A paper recently published in Cells has described how Immunophotonics' immune-stimulating drug IP-001 was shown to be effective against metastatic...
Read More